ClinicalTrials.govpublic full text
Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease
fabry disease, amicus therapeutics, galafold, at1001, migalastat, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850490
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.